Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
This guide covers what to know about dividend investing for beginners, offering essential insights to help you succeed in the market.
14,359 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
What would it look like if a legendary duo concentrated nearly $80 billion into one stock? This thought-provoking pie...
This in-depth analysis explores what could drive ASML stock in 2026, with practical scenarios, risk factors, and clea...
The crypto market kicked off 2026 with volatility, but three tokens jumped 25% or more. Dive into what drove these ga...
Gold bullion and gold miners offer distinct paths to hedge risk and diversify. This guide compares GDX and AAAU, brea...
LoanDepot posted a larger first-quarter loss as market volatility and thinner gain-on-sale margins weighed on revenue...
Joby Aviation stock today? Investors are asking why the shares moved. This article breaks down the catalysts, what’s ...
Take a practical tour of arcutis (arqt) 2026 earnings, from revenue mix and margins to pipeline progress and risk fac...
A major institutional move signals a shift in risk tolerance and strategy. Learn what arcus capital scales back means...
In today’s stock market today, Nokia priced lower by about 6% as traders weigh AI hype against fundamentals. This pie...
Investors are watching Cytek's 2026 earnings story unfold after Q1 results. This deep dive breaks down the key driver...
The AI boom isn’t over yet, according to seasoned investor Paul Tudor Jones Says. This piece breaks down why the rall...